Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
193.19M
Market cap193.19M
Price-Earnings ratio
-0.95
Price-Earnings ratio-0.95
Dividend yield
Dividend yield
Average volume
312.66K
Average volume312.66K
High today
$13.85
High today$13.85
Low today
$12.90
Low today$12.90
Open price
$12.90
Open price$12.90
Volume
366.61K
Volume366.61K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$11.60
52 Week low$11.60

Stock Snapshot

Tonix Pharmaceuticals(TNXP) stock is priced at $13.20, giving the company a market capitalization of 193.19M. It carries a P/E multiple of -0.95.

During the trading session on 2026-05-03, Tonix Pharmaceuticals(TNXP) shares reached a daily high of $13.85 and a low of $12.90. At a current price of $13.20, the stock is +2.3% higher than the low and still -4.7% under the high.

Trading volume for Tonix Pharmaceuticals(TNXP) stock has reached 366.61K, versus its average volume of 312.66K.

The stock's 52-week range extends from a low of $11.60 to a high of $69.97.

The stock's 52-week range extends from a low of $11.60 to a high of $69.97.

TNXP News

TipRanks 2d
Tonix Pharma Announces Administrative Update to Regulatory Filing

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d
Tonix Pharmaceuticals says on track to initiate Phase 2 study of TNX-4800

Tonix Pharmaceuticals (TNXP) announced presentation of Phase 1 data and plans for an adaptive Phase 2 field study of TNX-4800 for the prevention of Lyme disease...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.